ARIAD PHARMACEUTICALS INC 4
4 · ARIAD PHARMACEUTICALS INC · Filed Jul 16, 2015
Insider Transaction Report
Form 4
Haluska Frank
VP, Clinical R&D, CMO
Transactions
- Exercise/Conversion
Performance stock unit
2015-07-15−8,000→ 0 total→ Common Stock (8,000 underlying) - Exercise/Conversion
Common Stock
2015-07-15+8,000→ 122,124 total - Sale
Common Stock
2015-07-16$8.54/sh−4,400$37,575→ 117,724 total
Footnotes (4)
- [F1]Shares were acquired upon vesting of performance stock units awarded on March 20, 2012.
- [F2]Represents shares sold to satisfy withholding tax requirements, pursuant to a Rule 10b5-1 trading plan.
- [F3]Each performance stock unit represents a right to receive one share of ARIAD common stock.
- [F4]The performance stock units vested on 7/15/15.